1-(4-((7-(Dimethylamino)quinazolin-4-yl)oxy)phenyl)-3-(1-methyl-1H-pyrazol-3-yl)methyl)urea

ID: ALA4878293

PubChem CID: 155206604

Max Phase: Preclinical

Molecular Formula: C22H23N7O2

Molecular Weight: 417.47

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccn(C)n4)cc3)ncnc2c1

Standard InChI:  InChI=1S/C22H23N7O2/c1-28(2)17-6-9-19-20(12-17)24-14-25-21(19)31-18-7-4-15(5-8-18)26-22(30)23-13-16-10-11-29(3)27-16/h4-12,14H,13H2,1-3H3,(H2,23,26,30)

Standard InChI Key:  YBJCLKLSVZHLQY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    2.2273  -14.0862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2261  -14.9099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9383  -15.3229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9365  -13.6773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6493  -14.0826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6500  -14.9057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3586  -15.3169    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0710  -14.9020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0662  -14.0757    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3530  -13.6724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3487  -12.8511    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0583  -12.4346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7677  -12.8469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4769  -12.4311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4730  -11.6090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7540  -11.2043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0478  -11.6183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1821  -11.1957    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8966  -11.5996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6058  -11.1863    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9020  -12.4167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5177  -15.3172    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8107  -14.9074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5163  -16.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3151  -11.5920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0212  -11.1805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7687  -11.5099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3130  -10.9003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9015  -10.1943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1029  -10.3675    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2308   -9.4463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
  2 22  1  0
 22 23  1  0
 22 24  1  0
 20 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 26  2  0
 29 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4878293

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 417.47

Molecular Weight (Monoisotopic): 417.1913

AlogP: 3.54

#Rotatable Bonds: 6

Polar Surface Area: 97.20

Molecular Species: NEUTRAL

HBA: 7

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.94

CX Basic pKa: 4.23

CX LogP: 2.99

CX LogD: 2.99

Aromatic Rings: 4

Heavy Atoms: 31

QED Weighted: 0.50

Np Likeness Score: -2.05

References

1. Lee KH, Yen WC, Lin WH, Wang PC, Lai YL, Su YC, Chang CY, Wu CS, Huang YC, Yang CM, Chou LH, Yeh TK, Chen CT, Shih C, Hsieh HP..  (2021)  Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model.,  64  (19.0): [PMID:34606263] [10.1021/acs.jmedchem.1c01006]

Source

Source(1):

• Scientific Literature